The U.S. Food and Drug Administration last week approved a genetic treatment for the blood disorder beta-thalassemia, marking the third U.S. gene therapy for a rare disease.
Sixteen months since the COVID-19 vaccination drive began and a third of the world’s population hasn’t yet received a single dose of the vaccine. A shocking 83 percent of all Africans are in the same boat, said the head...
